Alembic to skip first wave of global semaglutide launches, eyes India

February 5, 2026
No Comments
6 Min Read

Alembic Pharmaceuticals said it will miss the first wave of global generic semaglutide launches but is exploring partnerships for a faster entry into the Indian market

Source :- Companies Read More

Share it :

Leave a Reply Cancel reply

Get free tips and resources right in your inbox, along with 10,000+ others

Latest Post

Bitcoin demand turns positive in spot, perpetual markets as price rebounds above $70K; hits 11-week high

August 21, 2026

These three copper stocks are riding India’s energy expansion. Should you invest?

August 21, 2026

Stocks to watch: HAL, RailTel, Tata Motors PV among shares in focus today; check list here

August 21, 2026

Can Augmont Enterprises IPO deliver long-term growth for high-risk investors?

August 21, 2026

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 21 August 2026

August 21, 2026

Treasury heads in buying mode as 5-year yield jumps

August 21, 2026

Alembic to skip first wave of global semaglutide launches, eyes India

Leave a Reply Cancel reply

Get free tips and resources right in your inbox, along with 10,000+ others

Categories

Latest Post

Categories

Useful Link

Company